Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Insights

Chapter 2 Market Overview
High-Content Screening Technology Overview
High-Throughput Screening (HTS)
Process Involved in High-Throughput Screening
Developments in HTS

Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing R&D Budgets
Technological Advances in HCS/I
Market Restraints and Challenges
High Equipment Costs
Data Management Challenges
Opportunities in the Market
Opportunities in 3D Applications
Emerging Economies

Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
AI for High-Content Image Analysis
Cell Painting
3D Organoid, Tumoroid and Spheroid Cultures

Chapter 5 Market Segment Analysis
Segmentation Breakdown
Market Analysis by Component
Instruments
Consumables
Software and Analytics
Services
Market Analysis by Application
Primary and Secondary Screening
Target Identification and Validation
Compound Profiling
Toxicity Studies
Other Applications
Market Analysis by End User
Pharmaceutical Companies
Academics
Laboratories and Pathology Centers
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of Asia-Pacific
Rest of the World (RoW)

Chapter 6 Competitive Intelligence
Company Share Analysis
Strategic Analysis
Partnerships
Mergers and Acquisitions
Product Launches
Pricing Analysis

Chapter 7 Patent Review
Patent Review
Patent Review by Year
Patent Review by Jurisdiction
Patent Review by Top Applicants
Selected Granted Patents

Chapter 8 Sustainability in the HCS/I Market: An ESG Perspective
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
Understanding the ESG Data
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance

Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
BIO-RAD LABORATORIES INC.
BRUKER
CHARLES RIVER LABORATORIES
CORNING INC.
DANAHER CORP.
EVIDENT
MERCK KGAA
MILTENYI BIOTEC
REVVITY
SARTORIUS AG
THERMO FISHER SCIENTIFIC INC.
YOKOGAWA ELECTRIC CORP.
ZEISS



List of Figures


Summary Figure : Shares of Global Market for HCS/I, by Region, 2023
Figure 1 : HCS Applications
Figure 2 : HCS in Drug Discovery
Figure 3 : Methodology for Data Analysis in the HCS/I Market
Figure 4 : Essential Tools for HCS
Figure 5 : Advantages of HTS
Figure 6 : Applications of High-Throughput Screening
Figure 7 : Market Dynamics of HCS/I Technology
Figure 8 : Technological Advances in HCS
Figure 9 : Emerging Technologies in the HCS/I Market
Figure 10 : Shares of Global Market for HCS/I, by Component, 2023
Figure 11 : Global Market for HCS/I, by Region, 2021-2029
Figure 12 : Global Market for HCS/I Instruments, 2021-2029
Figure 13 : Shares of Global Market for HCS/I Instruments, by Type, 2023
Figure 14 : Microplate Reader Categories
Figure 15 : Global Market for HCS/I Consumables, 2021-2029
Figure 16 : General Steps Involved in HCS/I Software Analysis
Figure 17 : Global Market for HCS/I Software and Analytics, 2021-2029
Figure 18 : Global Market for HCS/I Services, 2021-2029
Figure 19 : Shares of Global Market for HCS/I, by Application, 2023
Figure 20 : Features of a Lead Compound
Figure 21 : Global Market for Primary and Secondary Screening Applications in HCS/I, 2021-2029
Figure 22 : Global Market for Target Identification and Validation in HCS/I, 2021-2029
Figure 23 : Strategies to Improve Screening Using Compound Profiling
Figure 24 : Global Market for Compound Profiling in HCS/I, 2021-2029
Figure 25 : Global Market for HCS/I in Toxicity Studies, 2021-2029
Figure 26 : Global Market for HCS/I in Other Applications, 2021-2029
Figure 27 : Global Market Shares of HCS/I, by End User, 2023
Figure 28 : Global HCS/I Market for Pharmaceutical Companies, 2021-2029
Figure 29 : Global HCS/I Market for Academics, 2021-2029
Figure 30 : Global HCS/I Market for Laboratories and Pathology Centers, 2021-2029
Figure 31 : Shares of Global Market for HCS/I, by Region, 2023
Figure 32 : Global Market for HCS/I, by Region, 2021-2029
Figure 33 : Shares of North American Market for HCS/I, by Country, 2023
Figure 34 : U.S. Market for HCS/I, 2021-2029
Figure 35 : Canadian Market for HCS/I, 2021-2029
Figure 36 : Mexican Market for HCS/I, 2021-2029
Figure 37 : European Market Shares of HCS/I, by Country, 2023
Figure 38 : German Market for HCS/I, 2021-2029
Figure 39 : French Market for HCS/I, 2021-2029
Figure 40 : Italian Market for HCS/I, 2021-2029
Figure 41 : Spanish Market for HCS/I, 2021-2029
Figure 42 : U.K. Market for HCS/I, 2021-2029
Figure 43 : Rest of European Market for HCS/I, 2021-2029
Figure 44 : Shares of Asia-Pacific Market for HCS/I, by Country, 2023
Figure 45 : Chinese Market for HCS/I, 2021-2029
Figure 46 : Japanese Market for HCS/I, 2021-2029
Figure 47 : Indian Market for HCS/I, 2021-2029
Figure 48 : South Korean Market for HCS/I, 2021-2029
Figure 49 : Australian Market for HCS/I, 2021-2029
Figure 50 : Rest of Asia-Pacific Market for HCS/I, 2021-2029
Figure 51 : Shares of Global Market for HCS/I, by Company, 2023
Figure 52 : Strategies Adopted by Companies in the HCS/I Industry
Figure 53 : Granted HCS/I Patents, by Year, 2021-2024
Figure 54 : Granted HCS/I Patents, by Jurisdiction, 2021-2024
Figure 55 : Top Applicants for Granted HCS/I Patents, 2021-2024
Figure 56 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 57 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 58 : BD: Revenue Share, by Business Unit, FY 2023
Figure 59 : BD: Revenue Share, by Country/Region, FY 2023
Figure 60 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 61 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 62 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 63 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 64 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 65 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 66 : Corning Inc.: Revenue Share, by Business Unit, FY 2023
Figure 67 : Corning Inc.: Revenue Share, by Country/Region, FY 2023
Figure 68 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 69 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 70 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 71 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 72 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 73 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 74 : Sartorius AG: Revenue Share by Business Unit, FY 2023
Figure 75 : Sartorius AG: Revenue Share, by Country/Region, FY 2023
Figure 76 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 77 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Figure 78 : Yokogawa Electric Corp.: Revenue Share, by Business Unit, FY 2023
Figure 79 : Yokogawa Electric Corp.: Revenue Share, by Country/Region, FY 2023
Figure 80 : Zeiss: Revenue Share, by Business Unit, FY 2023
Figure 81 : Zeiss: Revenue Share, by Country/Region, FY 2023

List of Tables


Summary Table : Global Market for HCS/I, by Region, Through 2029
Table 1 : HTS Detection Methods
Table 2 : R&D Expenditure of Key Pharmaceutical Companies, 2023
Table 3 : Global Market for HCS/I, by Component, Through 2029
Table 4 : Global Market for HCS/I Instruments, by Region, Through 2029
Table 5 : Global Market for HCS/I Instruments, by Type, Through 2029
Table 6 : Selected Imaging Devices Available in the Market
Table 7 : Global Market for Imaging Devices in HCS/I, by Region, Through 2029
Table 8 : Selected Cytometers for Cellomics
Table 9 : Global Market for HCS/I Cytometers, by Region, Through 2029
Table 10 : Global Market for Plate Readers in HCS/I, by Region, Through 2029
Table 11 : Global Market for Light Sources in HCS/I, by Region, Through 2029
Table 12 : Global Market for Detectors and Sensors in HCS/I, by Region, Through 2029
Table 13 : Global Market for Liquid Handling Instruments in HCS/I, by Region, Through 2029
Table 14 : Global Market for HCS/I Consumables, by Region, Through 2029
Table 15 : Global Market for HCS/I Software and Analytics, by Region, Through 2029
Table 16 : Global Market for HCS/I Services, by Region, Through 2029
Table 17 : Global Market for HCS/I, by Application, Through 2029
Table 18 : Global Market for Primary and Secondary Screening Applications in HCS/I, by Region, Through 2029
Table 19 : Global Market for Target Identification and Validation in HCS/I, by Region, Through 2029
Table 20 : Global Market for Compound Profiling in HCS/I, by Region, Through 2029
Table 21 : Toxicology Applications of HCS/I
Table 22 : Global Market for HCS/I in Toxicity Studies, by Region, Through 2029
Table 23 : Global Market for HCS/I in Other Applications, by Region, Through 2029
Table 24 : Global Market for HCS/I, by End User, Through 2029
Table 25 : Global HCS/I Market for Pharmaceutical Companies, by Region, Through 2029
Table 26 : Global HCS/I Market for Academics, by Region, Through 2029
Table 27 : Global HCS/I Market for Laboratories and Pathology Centers, by Region, Through 2029
Table 28 : Global Market for HCS/I, by Region, Through 2029
Table 29 : North American Market for HCS/I, by Country, Through 2029
Table 30 : North American Market for HCS/I, by Component, Through 2029
Table 31 : North American Market for HCS/I Instruments, by Type, Through 2029
Table 32 : North American Market for HCS/I, by Application, Through 2029
Table 33 : North American Market for HCS/I, by End User, Through 2029
Table 34 : European Market for HCS/I, by Country, Through 2029
Table 35 : European Market for HCS/I, by Component, Through 2029
Table 36 : European Market for HCS/I Instruments, by Type, Through 2029
Table 37 : European Market for HCS/I, by Application, Through 2029
Table 38 : European Market for HCS/I, by End User, Through 2029
Table 39 : Asia-Pacific Market for HCS/I, by Country, Through 2029
Table 40 : Asia-Pacific Market for HCS/I, by Component, Through 2029
Table 41 : Asia-Pacific Market for HCS/I Instruments, by Type, Through 2029
Table 42 : Asia-Pacific Market for HCS/I, by Application, Through 2029
Table 43 : Asia-Pacific Market for HCS/I, by End User, Through 2029
Table 44 : RoW Market for HCS/I, by Component, Through 2029
Table 45 : RoW Market for HCS/I Instruments, by Type, Through 2029
Table 46 : RoW Market for HCS/I, by Application, Through 2029
Table 47 : RoW Market for HCS/I, by End User, Through 2029
Table 48 : Selected Strategic Alliances in the HCS/I Industry, 2023 and 2024
Table 49 : Select M&A Activities in the AI in the Cancer Industry, 2024
Table 50 : Product Launches in the HCS/I Industry, 2021-2024
Table 51 : Average Selling Price of HCS/I Products
Table 52 : Selected Patents Issued in HCS/I Industry, 2021-2024
Table 53 : ESG Rankings for Major HCS/I Companies, as of September 2024
Table 54 : ESG: Environmental Overview
Table 55 : ESG: Social Overview
Table 56 : ESG: Governance Overview
Table 57 : Information Sources in this Report
Table 58 : Abbreviations Used in the High Content Screening/Imaging Market
Table 59 : Agilent Technologies Inc.: Company Snapshot
Table 60 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Agilent Technologies Inc.: Product Portfolio
Table 62 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 63 : BD: Company Snapshot
Table 64 : BD: Financial Performance, FY 2022 and 2023
Table 65 : BD: Product Portfolio
Table 66 : BD: News/Key Developments, 2023
Table 67 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 68 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 69 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 70 : Bruker: Company Snapshot
Table 71 : Bruker: Financial Performance, FY 2022 and 2023
Table 72 : Bruker: Product Portfolio
Table 73 : Bruker: News/Key Developments, 2024
Table 74 : Charles River Laboratories: Company Snapshot
Table 75 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 76 : Charles River Laboratories: Product Portfolio
Table 77 : Corning Inc.: Company Snapshot
Table 78 : Corning Inc.: Financial Performance, FY 2022 and 2023
Table 79 : Corning Inc.: Product Portfolio
Table 80 : Danaher Corp.: Company Snapshot
Table 81 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 82 : Danaher Corp.: Product Portfolio
Table 83 : Danaher Corp.: News/Key Developments, 2021-2024
Table 84 : Evident: Company Snapshot
Table 85 : Evident: Product Portfolio
Table 86 : Evident: News/Key Developments, 2022 and 2023
Table 87 : Merck KGaA: Company Snapshot
Table 88 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 89 : Merck KGaA: Product Portfolio
Table 90 : Miltenyi Biotec: Company Snapshot
Table 91 : Miltenyi Biotec: Product Portfolio
Table 92 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
Table 93 : Revvity: Company Snapshot
Table 94 : Revvity: Financial Performance, FY 2022 and 2023
Table 95 : Revvity: Product Portfolio
Table 96 : Revvity: News/Key Developments, 2023
Table 97 : Sartorius AG: Company Snapshot
Table 98 : Sartorius AG: Financial Performance, FY 2022 and 2023
Table 99 : Sartorius AG: Product Portfolio
Table 100 : Sartorius AG: News/Key Developments, 2023
Table 101 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 102 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 103 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 104 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
Table 105 : Yokogawa Electric Corp.: Company Snapshot
Table 106 : Yokogawa Electric Corp.: Financial Performance, FY 2022 and 2023
Table 107 : Yokogawa Electric Corp.: Product Portfolio
Table 108 : Yokogawa Electric Corp.: News/Key Developments, 2024
Table 109 : Zeiss: Company Snapshot
Table 110 : Zeiss: Financial Performance, FY 2022 and 2023
Table 111 : Zeiss: Product Portfolio
Table 112 : Zeiss: News/Key Developments, 2023 and 2024